JPRN-UMIN000042547已完成未知
The efficacy and safety of treatment with zoledronic acid in patients and the influence of patient characteristics. - The efficacy and safety of treatment with zoledronic acid in patients and the influence of patient characteristics.
Koenji Orthopedics Clinic0 个研究点目标入组 88 人开始时间: 2020年11月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 55years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Patients with a metabolic bone disease other than osteoporosis 2. Patients with a history of hypersensitivity to the study drug or BP 3. Patients who have severe renal impairment (creatinine clearance < 35 mL/min) at the start 4. Patients who are dehydrated (high fever, severe diarrhea and vomiting, etc.) at the start 5. Patients who have hypocalcemia at the start 6. Patients whom the physicians judged to be unsuitable because of idiosyncratic complications and markedly different background
研究者
相似试验
招募中
不适用
Comparative safety and effectiveness of zoledronic acid versus denosumab in osteoporosis patients with vertebral compression fractureKCT0005424Gachon University Gil Medical Center80
已完成
不适用
To find out effect of Injection Zoledronic acid for treatment of bone weakening condition in patients having long term liver problems/damage.CTRI/2020/03/024247Pt BD Sharma PGIMS Rohtak49
招募中
2 期
The LoPeZ studyMetastatic non-small cell lung carcinoma with bony metastasesCancer - Lung - Non small cellCancer - BoneACTRN12606000079549Peter MacCallum Cancer Centre14
已完成
Unknown
A new study to minimise the side effects of rapid maxillary expansioSide effects of rapid maxillary expansion (RME) on dental and buccal alveolar bone changesOral HealthISRCTN16744226Damascus University32
已完成
4 期
Zoledronate and fracture prevention in early postmenopausal womeMusculoskeletal - OsteoporosisOsteoporosisACTRN12612000270819Dr Mark Bolland1,054